Saturn V Capital Management LP
23 holdingsFiling period: 2026-06-30Current AUM: $590.5Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | AMLX | Amylyx Pharmaceuticals Inc | 4.62M | $83.0M | $125.3M | 21.21% | +274.2K | 2026-06-30 |
| 2 | ALMS | Alumis Inc | 2.92M | $82.0M | $19.0M | 3.21% | -286,632 | 2026-06-30 |
| 3 | ABVX | Abivax SA | 518.9K | $69.1M | $44.9M | 7.60% | -23,831 | 2026-06-30 |
| 4 | PCVX | Vaxcyte Inc | 852.9K | $49.6M | $51.1M | 8.66% | +28.4K | 2026-06-30 |
| 5 | IMMX | Immix Biopharma Inc | 4.66M | $48.0M | $37.5M | 6.36% | +964.8K | 2026-06-30 |
| 6 | — | Pharvaris N V | 1.31M | $45.4M | $45.4M | 7.70% | +112.7K | 2026-06-30 |
| 7 | — | Jazz Pharmaceuticals PLC | 160.9K | $38.8M | $38.8M | 6.57% | -2,023 | 2026-06-30 |
| 8 | CELC | Celcuity Inc | 370.3K | $38.7M | $24.4M | 4.13% | +88.4K | 2026-06-30 |
| 9 | IRON | Disc Medicine Inc | 524.7K | $38.4M | $40.7M | 6.90% | +74.8K | 2026-06-30 |
| 10 | CADL | Candel Therapeutics Inc | 3.30M | $34.0M | $25.7M | 4.36% | +407.1K | 2026-06-30 |
| 11 | XFOR | X4 Pharmaceuticals Inc | 6.97M | $32.6M | $22.7M | 3.84% | +516.7K | 2026-06-30 |
| 12 | MNPR | Monopar Therapeutics Inc | 312.0K | $28.9M | $22.0M | 3.73% | -33,650 | 2026-06-30 |
| 13 | DYN | Dyne Therapeutics Inc | 1.06M | $23.5M | $16.6M | 2.82% | +90.9K | 2026-06-30 |
| 14 | TRVI | Trevi Therapeutics Inc | 1.05M | $19.6M | $13.2M | 2.23% | -- | 2026-06-30 |
| 15 | — | Zura Bio Ltd | 2.10M | $12.4M | $12.4M | 2.10% | +1.36M | 2026-06-30 |
| 16 | SGMT | Sagimet Biosciences Inc | 1.48M | $11.4M | $14.1M | 2.40% | -- | 2026-06-30 |
| 17 | — | Oculis Holding AG | 684.9K | $9.5M | $9.5M | 1.61% | +168.1K | 2026-06-30 |
| 18 | IKT | Inhibikase Therapeutics Inc | 3.87M | $7.9M | $5.9M | 1.00% | +5.6K | 2026-06-30 |
| 19 | VIR | Vir Biotechnology Inc | 770.6K | $7.9M | $8.5M | 1.44% | -- | 2026-06-30 |
| 20 | IVVD | Invivyd Inc | 8.39M | $7.3M | $4.9M | 0.84% | -2,556,796 | 2026-06-30 |
| 21 | ANRO | Alto Neuroscience Inc | 182.8K | $4.8M | $4.0M | 0.68% | +93.8K | 2026-06-30 |
| 22 | MSLE | Satellos Bioscience Inc | 350.0K | $2.7M | $2.3M | 0.39% | -- | 2026-06-30 |
| 23 | OVID | Ovid Therapeutics Inc | 663.1K | $1.8M | $1.4M | 0.24% | -3,503,606 | 2026-06-30 |
← Scroll →